服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-CCR8/CKR-L1/CDw198 mAbs [Azirkitug Biosimilar] (MABL-4418) | MABL-4418 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EGFR/ERBB1/HER1;MET/HGFR mAbs [Bafisontamab Biosimilar] (MABL-4419) | MABL-4419 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-CD70 mAbs [Balertatug Biosimilar] (MABL-4420) | MABL-4420 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NPR1/ANPRA/ANPa/GUC2A/GUCY2A/NPRA mAbs [Balonkibart Biosimilar] (MABL-4421) | MABL-4421 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Balstilimab Biosimilar] (MABL-4422) | MABL-4422 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike mAbs [Bamlanivimab Biosimilar] (MABL-4423) | MABL-4423 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-APP mAbs [Bapineuzumab Biosimilar] (MABL-4424) | MABL-4424 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ILDR2 mAbs [Bapotulimab Biosimilar] (MABL-4425) | MABL-4425 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-ERBB3/HER3 mAbs [Barecetamab Biosimilar] (MABL-4426) | MABL-4426 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-KIT/CD117 mAbs [Barzolvolimab Biosimilar] (MABL-4427) | MABL-4427 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL2RA/CD25 mAbs [Basiliximab Biosimilar] (MABL-4428) | MABL-4428 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FCGRT/FcRn mAbs [Batoclimab Biosimilar] (MABL-4429) | MABL-4429 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Phosphatidylserine mAbs [Bavituximab Biosimilar] (MABL-4430) | MABL-4430 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LAG3/CD223;CTLA4/CD152 mAbs [Bavunalimab Biosimilar] (MABL-4431) | MABL-4431 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-ACVRL1/SKR3 mAbs [Ascrinvacumab Biosimilar] (MABL-4400) | MABL-4400 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-L-Selectin mAbs [Aselizumab Biosimilar] (MABL-4401) | MABL-4401 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL1RL1/ST2 mAbs [Astegolimab Biosimilar] (MABL-4402) | MABL-4402 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-TNFRSF9/CD137/4-1BB mAbs [Atenastobart Biosimilar] (MABL-4403) | MABL-4403 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-PDL1/CD274 mAbs [Atezolizumab Biosimilar] (MABL-4404) | MABL-4404 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD14 mAbs [Atibuclimab Biosimilar] (MABL-4405) | MABL-4405 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn